Morarka Finance Limited (MORARKFI.BO)
INR 156.25
(-0.73%)
INR 156.25
(-0.73%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 42.36 Million | -5.5 Million | -1.63 Million | -54.77 Million | -893.21 Thousand | 702.53 Thousand |
| Net Income | 63.15 Million | 54.73 Million | 40.52 Million | 9.17 Million | 49.75 Million | 5.34 Million |
| Depreciation & Amortization | 29 Thousand | 31 Thousand | 32 Thousand | 34 Thousand | 35.92 Thousand | 38.05 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -44.6 Million | -7.23 Million | -3.45 Million | -56.96 Million | -2.02 Million | -216.68 Thousand |
| Other non-cash items | 23.44 Million | -53.03 Million | -38.73 Million | -7.02 Million | -48.66 Million | -4.46 Million |
| Investing Cash Flow | -19.35 Million | 22.61 Million | 6.97 Million | 32.39 Million | 23.66 Million | 4.71 Million |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | -42 Million | -42.5 Million | -23 Million | -80.99 Million | -25 Million | - |
| Sales/Maturities of investments | 22.64 Million | 18.9 Million | - | 106.8 Million | 955.00 | 248.69 Thousand |
| Other Investing Activities | 46.22 Million | 46.21 Million | 29.97 Million | 6.58 Million | 48.66 Million | 4.46 Million |
| Financing Cash Flow | -22.51 Million | -18 Million | -4.5 Million | - | - | -5.42 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | -22.51 Million | -18 Million | -4.5 Million | - | - | -5.42 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | - | - | - | -925.42 Thousand |
| Accounts receivables | 504 Thousand | -2.95 Million | -1.9 Million | -587.52 Thousand | 89.48 Thousand | 177.16 Thousand |
| Accounts payables | -5000.00 | 4000.00 | 2000.00 | -18.47 Thousand | 16.53 Thousand | 154.93 Thousand |
| Inventory | -103 Thousand | -268 Thousand | -132 Thousand | -225 Thousand | 322.44 Thousand | 130.95 Thousand |
| Other working capital | -44.99 Million | -4.01 Million | -1.42 Million | -56.13 Million | -2.45 Million | -679.74 Thousand |
| Cash at beginning of period | 984 Thousand | 1.88 Million | 1.05 Million | 23.43 Million | 661.24 Thousand | 673.01 Thousand |
| Cash at end of period | 380 Thousand | 984 Thousand | 1.88 Million | 1.05 Million | 23.43 Million | 661.24 Thousand |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -604 Thousand | -902 Thousand | 834 Thousand | -22.38 Million | 22.77 Million | -11.76 Thousand |
| Free Cash Flow | 42.36 Million | -5.5 Million | -1.63 Million | -54.77 Million | -893.21 Thousand | 702.53 Thousand |
| Breakdown | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY | 2022 Q4 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 63.15 Million | 3.73 Million | 6.05 Million | 48.08 Million | 54.73 Million | -4.27 Million |
| Depreciation & Amortization | 29 Thousand | 8000.00 | 7000.00 | 7000.00 | 31 Thousand | 8000.00 |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -44.6 Million | - | - | - | -7.23 Million | - |
| Other non-cash items | 23.44 Million | -8000.00 | -7000.00 | -7000.00 | -53.03 Million | -8000.00 |
| Investing Cash Flow | -19.35 Million | - | - | - | 22.61 Million | - |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | -42 Million | - | - | - | -42.5 Million | - |
| Sales/Maturities of investments | 22.64 Million | - | - | - | 18.9 Million | - |
| Other Investing Activities | - | - | - | - | 46.21 Million | - |
| Financing Cash Flow | -22.51 Million | - | - | - | -18 Million | - |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | -22.51 Million | - | - | - | -18 Million | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | - | - | - | - |
| Accounts receivables | 504 Thousand | - | - | - | -2.95 Million | - |
| Accounts payables | -5000.00 | - | - | - | 4000.00 | - |
| Inventory | -103 Thousand | - | - | - | -268 Thousand | - |
| Other working capital | -44.99 Million | - | - | - | -4.01 Million | - |
| Cash at beginning of period | 984 Thousand | 24 Million | 17.95 Million | 984 Thousand | 1.88 Million | 5.26 Million |
| Cash at end of period | 380 Thousand | 3.73 Million | 24 Million | 48.08 Million | 984 Thousand | 984 Thousand |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -604 Thousand | -20.27 Million | 6.05 Million | 47.1 Million | -902 Thousand | -4.27 Million |
| Free Cash Flow | 42.36 Million | 3.73 Million | 6.05 Million | 48.08 Million | -5.5 Million | -4.27 Million |
WONDF
BIOPOR
GVKPIL
YULE
NVG
SWRNASE